Proteinuria is an independent risk factor for ischemic stroke in non- insulin-dependent diabetes mellitus

Stroke

Volumn 30, Issue 9, 1999, Pages 1787-1791

  Guerrero Romero, Fernando ^a,b,d   Rodríguez Morán, Martha ^b,c  

^a Medical Research Unit In Clinical Epidemiology   (Mexico)

^b Res Grp Diabet/Chron Illnesses   (Mexico)

^c Gen Hosp Mex Social Secty Inst   (Mexico)

^d NONE   (Mexico)

Author keywords

Diabetes mellitus; Proteinuria; Stroke, ischemic

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; SMOKING; STROKE;

EID: 0344631725     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.30.9.1787     Document Type: Article

References (33)

1. Pyorala K, Laakso M, Uusiutupa M. Diabetes and atherosclerosis: an epidemiological review. Diabetes Metab Rev. 1987;3:463-524.
2. Kannel WB, Stampfer MJ, Castelli WP, Verter J. The prognostic significance of proteinuria: the Framingham Study. Am Heart J. 1984; 108:1347-1352.
3. Viberti G. Etiology and prognostic significance of albuminuria in diabetes. Diabetes Care. 1988;11:840-845.
4. American Diabetes Association. Clinical practice recommendations 1997: diabetic nephropathy. Diabetes Care. 1997;20(suppl 1): S24-S27.
5. Eastman RC, Keen H. The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet. 1997;350(suppl 1):29-32.
6. Guerrero-Romero F, Rodríguez-Morán M. Relationship of microalbuminuria with the diabetic foot ulcers in type 2 diabetes. J Diabetes Complications. 1998;12:193-196.
7. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the steno-hypothesis. Diabetologia. 1989;32:219-226.
8. Savage S, Estacio RO, Jeffers B, Schrier RW. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care. 1996;19: 1243-1248.
9. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke. 1996;27:2033-2039.
10. Guerrero Romero F, Rodríguez Morán M. Diabetes mellitus: un análisis de mortalidad por causa básica. Rev Med, IMSS. 1996;34: 43-48.
11. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
12. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology. 1995;45:(2 suppl 1)S10-S14.
13. Guerrero-Romero JF, Rodríguez-Morán M, Lazcano-Burciaga G, Arellano-Rojas T, Carrillo-Soto VM, Solís Morales H. Prevalencia y factores de riesgo asociados a complicaciones vasculares en pacientes con diabetes mellitus no insulino dependiente. Rev Invest Clin SS, IMSS. 1997;2:19-23.
14. Selby JV, FitzSimmons SC, Newman JM, Katz PP, Sepe S, Showstack J. The natural history and epidemiology of diabetic nephropathy: implications for prevention and control. JAMA. 1990;263:1954-1960.
15. Mejia-Aranguré JM, Fajardo-Gutiérrez A, Gómez-Delgado A, Cuevas-Urióstegui ML, Hernández-Hernández DM, Garduño-Espinoza J, Navarrete-Navarro S, Velásquez-Péres L, Martínez-García MC. El tamaño de muestra: un enfoque práctico en la investigación clínica. Bol Med Hosp Infant Mex. 1995;52:381-391.
16. World Health Organization. Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and protocol (MONICA Project). Geneva, Switzerland: World Health Organization; 1983. Publication WHO/MNC/82.1, revision 1.
17. You RX, McNeil JJ, O'Malley HM, Davis SM, Thrift AG, Donnan GA. Risk factors for stroke due to cerebral infarction in young adults. Stroke. 1997;28:1913-1918.
18. Tuomilehto J, Rastenyte D, Jousilahti P, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke. 1996;27:210-215.
19. Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990;21:701-706.
20. Barrett-Connor E, Khaw KT. Diabetes mellitus: an independent risk factor for stroke? Am J Epidemiol. 1988;128:116-123.
21. Knobl P, Schernthaner G, Schnack C, Pietschmann P, Griesmacher A, Prager R, Muller M. Thrombogenic factors are related to urinary albumin excretion in type I (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 1993;36: 1045-1050.
22. Sasaki A, Horiuchi N, Hasegawa K, Uheara M. Mortality from coronary heart disease and cerebrovascular disease and associated risk factors in diabetic patients in Osaka District, Japan. Diabetes Res Clin Pract. 1995;27:77-83.
23. Morrish NJ, Stevens LK, Fuller JH, Jarret RJ, Keen H. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO Multinational Study of Vascular Disease in Diabetics. Diabetologia. 1991;34:590-594.
24. Furman BL. Impairment of glucose tolerance produced by diuretics and other drugs. Pharmacol Ther. 1981;12:613-649.
25. Berne C, Pollare T, Lithell H. Effects of antihypertensive treatment on insulin sensitivity with special reference to ACE inhibitors. Diabetes Care. 1991;14(suppl 4):39-47.
26. Gurwitz JH, Bonn RL, Glynn RJ, Monane M, Mogun H, Avorn J. Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus. Ann Intern Med. 1993;118:273-278.
27. Rastenyte D, Tuomilehto J, Domarkiene S, Cepaitis Z, Reklaitiene R. Risk factors for death from stroke in middle-aged Lithuanian men: results from a 20-year prospective study. Stroke. 1996;27:672-676.
28. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke. 1994;25:1157-1164.
29. Lehto S, Rönnemaa Y, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke. 1996;27:63-68.
30. Guerrero Romero F, Rodríguez Morán M. Complicaciones relacionadas con la mortalidad por diabetes mellitus: un análisis de mortalidad por causa múltiple. Med Int Mex. 1997;13:263-267.
31. Murai A, Tanaka T, Miyahara T, Kameyama M. Lipoprotein abnormalities in the pathogenesis of cerebral infarction and transient ischemic attack. Stroke. 1981;12:167-172.
32. Tilvis RS, Erkinjuntti T, Sulkava R, Färkkila M, Miettinen TA. Serum lipids and fatty acids in ischemic strokes. Am Heart J. 1987;113: 615-619.
33. Davis T, Millns H, Stratton I, Holman R, Turner R; for the UK Prospective Diabetes Study Group. Risk factors for stroke in type 2 diabetes mellitus. Arch Intern Med. 1999;159:1097-1103.